Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction

Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction

Bibliographic Details
Main Authors: M Rizzo, I Colomer-Asenjo, G Cabello-Molina, S Marín-López, M Sutil-Vega, C Roca-Guerrero, F Taibi-Hajjami, D García-Vega, M Panelo-Rubio, M Bonastre-Thio, A Martínez-Rubio
Format: Article
Language:English
Published: Radcliffe Medical Media 2020-05-01
Series:European Cardiology Review
Online Access:https://www.ecrjournal.com/articleindex/ecr.2020.15.1.PO9
id doaj-13a7748dffbb483bbadb61a818cf6ee8
record_format Article
spelling doaj-13a7748dffbb483bbadb61a818cf6ee82021-10-09T16:02:26ZengRadcliffe Medical MediaEuropean Cardiology Review 1758-37561758-37642020-05-0115e3210.15420/ecr.2020.15.1.PO9Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection FractionM Rizzo0I Colomer-Asenjo1G Cabello-Molina2S Marín-López3M Sutil-Vega4C Roca-Guerrero5F Taibi-Hajjami6D García-Vega7M Panelo-Rubio8M Bonastre-Thio9A Martínez-Rubio10Sabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, Spainhttps://www.ecrjournal.com/articleindex/ecr.2020.15.1.PO9
collection DOAJ
language English
format Article
sources DOAJ
author M Rizzo
I Colomer-Asenjo
G Cabello-Molina
S Marín-López
M Sutil-Vega
C Roca-Guerrero
F Taibi-Hajjami
D García-Vega
M Panelo-Rubio
M Bonastre-Thio
A Martínez-Rubio
spellingShingle M Rizzo
I Colomer-Asenjo
G Cabello-Molina
S Marín-López
M Sutil-Vega
C Roca-Guerrero
F Taibi-Hajjami
D García-Vega
M Panelo-Rubio
M Bonastre-Thio
A Martínez-Rubio
Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
European Cardiology Review
author_facet M Rizzo
I Colomer-Asenjo
G Cabello-Molina
S Marín-López
M Sutil-Vega
C Roca-Guerrero
F Taibi-Hajjami
D García-Vega
M Panelo-Rubio
M Bonastre-Thio
A Martínez-Rubio
author_sort M Rizzo
title Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
title_short Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
title_full Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
title_fullStr Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
title_full_unstemmed Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
title_sort tolerability profile and discontinuation causes of sacubitril/valsartan treatment in ‘real-life’ patients with heart failure and reduced ejection fraction
publisher Radcliffe Medical Media
series European Cardiology Review
issn 1758-3756
1758-3764
publishDate 2020-05-01
url https://www.ecrjournal.com/articleindex/ecr.2020.15.1.PO9
work_keys_str_mv AT mrizzo tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction
AT icolomerasenjo tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction
AT gcabellomolina tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction
AT smarinlopez tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction
AT msutilvega tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction
AT crocaguerrero tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction
AT ftaibihajjami tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction
AT dgarciavega tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction
AT mpanelorubio tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction
AT mbonastrethio tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction
AT amartinezrubio tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction
_version_ 1716830349207535616

Similar Items